Executive Committee

The CONCERT Executive Committee is empowered to determine policy and oversees the conduct of CONCERT TCRC, and approves and supervises the delegation of authority to its various committees. The Executive Committee receives non-binding advice and input from both the Research Council and the T1/T2 and T2/T3 Working Research Committee (WRC) on affairs of CONCERT TCRC. The CONCERT Executive Committee meets every two months and comprises ten members.


Executive Committee Members


Professor Paul de Souza

Director of CONCERT

Professor Paul de Souza is the CONCERT TCRC Director, a medical oncologist, a Foundation Professor of Medical Oncology at the University of Western Sydney, a conjoint Professor in the Faculty of Medicine, UNSW Australia, and an Honorary Professor of the NHMRC Clinical Trials Centre, University of Sydney. After completion of his medical oncology training in Sydney, Paul was appointed as a Research Associate and later, an Assistant Professor of Medicine at the University of Virginia where he developed his clinical and research interests in cancer drug development. On his return to Sydney in 1997, he founded the Clinical Trials Unit in the Department of Medical Oncology of St George Hospital, as well as a research laboratory at St George Hospital dedicated to developing new drugs and methodologies for treatment of cancers. Paul completed his PhD in novel drug development at UNSW Australia. Since 2011, Paul has worked at Liverpool Hospital and the Ingham Institute, where he collaborates with a number of senior scientists. Paul has been a principal clinical investigator for over 40 clinical trials, specialising in all aspects of clinical trials from Phase I to IV. He currently runs the Phase I trials unit based at Liverpool Hospital. He has a strong research interest in translational cancer research. 


Professor Geoff Delaney

Deputy Director of CONCERT

Professor Geoff Delaney is the Deputy Director of CONCERT TCRC, Director of Cancer Services for the South Western Sydney Local Health District (SWSLHD), Director of Liverpool Cancer Centre, and a conjoint Professor at UNSW Australia and University of Western Sydney. He is an experienced Radiation Oncologist with his main areas of expertise being in breast cancer, radiation oncology, service planning and health services research. He has a PhD and an MD for research into radiation oncology. Geoff played a significant role in establishing the Collaboration for Cancer Outcomes Research and Evaluation (CCORE), a centre for oncology health services research situated at Liverpool Hospital. He has co-developed an incident reporting tool for radiation oncology. Geoff is the lead clinician in the development of an Area-Cancer Registry project for NSW Cancer Institute. As a co-investigator or principle investigator, he has been involved with 19 clinical trials conducted Sydney South West Local Health District in a wide variety of cancers. 


Professor Michael Barton

Michael Barton OAM is Professor of Radiation Oncology at UNSW, Research Director of the Ingham Institute for Applied Medical Research, and Collaboration for Cancer Outcomes Research & Evaluation (CCORE), Liverpool Hospital.  Professor Barton was awarded a Medal in the Order of Australia, June 2007, for his service to medicine, particularly radiation oncology, through a range of clinical, research, education and professional development roles. Professor Barton is recognised internationally for making major contributions to research in cancer services delivery and to academic and professional education in the field.  In 2000, he received the Professional Excellence in Education Award from the Cancer Council NSW. His leadership in oncology has been recognised by the awarding of the Medical Oncology Group of Australia-Novartis Oncology Cancer Achievement Award in 2012 and the Royal Australian and New Zealand College of Radiologists Rouse Travelling Fellowship in 2014. In 2007 he was nominated as the Rohan Williams Travelling Professor by the Royal College of Radiologists, London.


Professor Afaf Girgis

Professor Afaf Girgis is Director of the Psycho-oncology Research Group and a leading Australian behavioural scientist in Psycho-Oncology. She received the Clinical Oncology Society of Australia Inaugural Psycho-oncology Award in 2012 and over the past 25 years, she has gained an international reputation for research on development and psychometric testing of measures to assess cancer patients’, caregivers’ and health care professionals’ unmet needs; developing and psychometrically testing measures of psychological wellbeing; conducting complex multi-centre randomised controlled trials of psycho-oncology interventions; undertaking longitudinal studies to understand the longer-term impact of cancer on patients and caregivers; and managing large project budgets. Afaf has served on key state and national committees in behavioural and psychosocial research, professional training, cancer control and public health. Prof Girgis has been awarded more than $42.8 million in research funding and had more than 350 publications. 


Professor Marie Ranson

Professor Marie Ranson is a Professor of University of Wollongong, Chair of the CONCERT T1/T2 Working Research Committee, Chair of the University of Wollongong Gene Technology Review Committee, and a visiting research fellow at the Finsen Laboratory, University of Copenhagen Denmark and National Research Council of Italy. She completed her BSc in 1985 at UNSW Australia and Ph.D. in 1990 at University of Sydney. Marie has made major contributions in the field of the urokinase plasminogen activation system (PAS) in cancer invasion and metastasis and she leads several cancer drug discovery/development projects.  Marie has published over 70 peer-reviewed journal articles attracted several national competitive grants totalling over $10,000,000, and has raised over $500,000 from local charity donations for cancer research.  


  Professor Les Bokey

Prof Bokey is Professor of Colon and Rectal Surgery at the University of Western Sydney and Foundation Professor of Surgery. He is the Clinical Dean at the University of Western Sydney at Liverpool and Director of Surgery at the Liverpool hospital. He is also the Clinical Director of Gastroenterology/ Liver, Upper GI, Colorectal, Urology, Head & Neck Services for the Sydney South West Local Health District. Prof Bokey is an international authority on colorectal cancer and inflammatory bowel disease.  He has been awarded The Order of Australia Medal for service to medicine as colorectal surgeon and establishment of surgical education programs, research, and medical administration. He has received several honorary degrees from various International Universities and Societies.  He is currently the convenor of the Asia Pacific Endoscopic Colorectal Summit.  He is a reviewer for several international scientific journals. He is widely published and has received many grant applications including a recent NSW Cancer Institute grant in collaboration with the CONCERT program for $6.5million.


A/Professor Kevin Spring

Associate Professor Kevin Spring is the CONCERT Centre Fellow and holds an academic A/Prof appointment with the University of Western Sydney (UWS) and a conjoint A/Prof appointment at the UNSW.  He is also the deputy chair for the Centre for CTC Diagnostics and Research (CCDR) at the Ingham Institute. He is a leading member of the CINSW Biospecimen Stakeholder Network (BSN) Community of Practice Committee and is implementing a Clinical and Translational Informatics system to enhance biobankng and translational cancer research within the CONCERT network and SWS-LHD.  A/Prof Spring’s research expertise is in colorectal polyps and cancer, DNA damage recognition and repair, and in the clinical utility of circulating tumour cells (CTCs). He is the founding convenor for the Thomas Ashworth CTC Symposium and Australian CTC Society. A/Prof Spring made significant contributions to defining the serrated neoplasia pathway in the development of colorectal cancer in association with Profs Barbara Leggett and Jeremy Jass, both pioneers in the field.  A/Prof Spring also has seminal achievements in the function and role of ATM in the DNA damage response with publications in Nature Genetics, Nature, PNAS, JBC and Oncogene. He was the first to generate an Atm missense knockin mutant mouse and demonstrated cancer predisposition in AT heterozygotes.


 A/Professor Desmond Yip

Desmond Yip is the Clinical Director of Medical Oncology at The Canberra Hospital, Associate Professor at the ANU Medical School and an Adjunct Associate Professor at the University of Canberra. He was also the director of the Canberra Hospital Medical Oncology Research Unit. His main clinical and research interests are in the area of gastrointestinal oncology and development of biological agents. He also has subspecialty interests in renal cell carcinoma and gastrointestinal stromal tumours. He has been involved in the revisions of the NHMRC Clinical Guidelines in Colorectal Cancer and the Cochrane Collaboration systematic review of pharmacologic and radiotherapeutic treatments for advanced pancreatic cancer. He serves on the Cancer Institute NSW eviQ Medical Oncology Reference Committee and is an active member of the Australasian Gastrointestinal Trials Group and the Clinical Oncology Society of Australia. He has been involved in the publication of over 80 journal articles and invited book chapters.


 A/Professor Norbert Kienzle

Norbert Kienzle is the Manger and Strategic Development Executive for translational cancer research at the Ingham Institute for Applied Medical Research in Liverpool Sydney.Norbert has over ten years of leadership and management experiences in medical research and biopharmaceutical drug development, based on a scientific research track record in cancer biology, immunology and virology. He has authored more than 40 peer-reviewed publications and is an inventor on two PCT patent applications in therapeutic drug development. Norbert holds a PhD in Biology from the Albert-Ludwigs University (Freiburg, Germany); he has a Conjoint Associate Professor appointment with UNSW, SWS Clinical School, and Faculty of Medicine.


  Professor Soon Lee